Cumberland Pharmaceuticals (CPIX) Net Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Cumberland Pharmaceuticals (CPIX) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.71 Bn | 625.95 Bn | 17.26 Bn | -204.00 |
| 2 | AbbVie | 442.22 Bn | 435.65 Bn | 12.70 Bn | 666.00 |
| 3 | Merck | 366.92 Bn | 359.78 Bn | 12.21 Bn | 3,167.00 |
| 4 | Novartis Ag | 266.90 Bn | 259.21 Bn | 11.24 Bn | 240.00 |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | -1,956.00 |
| 6 | Sanofi | 52.44 Bn | 45.06 Bn | 10.79 Bn | -1,144.00 |
| 7 | Revolution Medicines | 44.11 Bn | 44.11 Bn | - | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 1,366.00 |
| 9 | United Therapeutics | 21.50 Bn | 18.84 Bn | 683.80 Mn | -94.00 |
| 10 | Cumberland Pharmaceuticals | 96.11 Mn | 92.24 Mn | - | -257,579.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -257,579.00 |
| Mar 31, 2026 | -3,627.00 |
| Dec 31, 2025 | 1,661.00 |
| Sep 30, 2025 | -1,980.00 |
| Jun 30, 2025 | -17,982.00 |
| Mar 31, 2025 | 2,321.00 |
| Dec 31, 2024 | 2,846.00 |
| Sep 30, 2024 | -345.00 |
| Jun 30, 2024 | -2,471.00 |
| Mar 31, 2024 | -2,376.00 |
| Dec 31, 2023 | -5,846.00 |
| Sep 30, 2023 | -516.00 |
| Jun 30, 2023 | 1,772.00 |
| Mar 31, 2023 | 1,465.00 |
| Dec 31, 2022 | -1,651.00 |
| Sep 30, 2022 | 2,465.00 |
| Jun 30, 2022 | -723.00 |
| Mar 31, 2022 | -1,209.00 |
| Dec 31, 2021 | -209.00 |
| Sep 30, 2021 | 613.00 |